According to a Form 4 filing submitted to the U.S. Securities and Exchange Commission on April 22, 2026, Jeffrey John Ronald Jr., serving as a director for ARGAN INC (NASDAQ: AGX), completed several notable transactions involving company equity. On April 21, 2026, Mr. Ronald Jr. engaged in both the sale of common stock and the exercise of previously awarded options.
The primary transaction involved an open market sale of 3,636 shares of ARGAN INC common stock. These shares were sold at an average price of $615.40 per share, resulting in total proceeds of $2,237,594. This sale occurred at a time when AGX is trading close to its 52-week high of $626.88, following a substantial one-year return of 362%. Following this specific disposal, the director no longer holds direct ownership of common stock from that particular holding.
Simultaneously, Mr. Ronald Jr. exercised an option to purchase 5,000 shares of common stock. These options were originally granted on December 14, 2021, with an exercise price of $37.13 per share. Through the application of a net settle method, he acquired 4,698 shares of common stock at a total cost of $174,436. After accounting for these combined activities, Mr. Ronald Jr.'s holdings consist of 4,698 shares of ARGAN INC common stock held directly. Additionally, he maintains an indirect ownership of 8,000 shares through an IRA and holds 6,500 unexercised options to purchase common stock.
Market Context and Corporate Financials
The timing of this insider activity coincides with a period of significant financial reporting for Argan Inc. The company's fourth-quarter results for fiscal year 2026 showed earnings per share (EPS) of $3.47, which was notably higher than the anticipated analyst forecast of $2.13. However, revenue performance for that same quarter reached $262.1 million, falling short of the expected $271.02 million.
In recent strategic moves to manage shareholder value, Argan Inc. has expanded its share repurchase program. The company increased the authorization from $150 million to $200 million, with the program now extended through January 31, 2030. Furthermore, the Board of Directors declared a quarterly cash dividend of $0.50 per common share. This dividend is scheduled for payment on April 30, 2026, to stockholders of record as of April 22, 2026.
While the stock has seen immense growth over the last year, current analysis from InvestingPro suggests that AGX may be overvalued at its present trading levels.